Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
The Use Of Umbilical Cord Blood As A Source Of Hematopoietic Stem Cells
NCT00084695Phase 2Unknown
- Sponsor
- Penn State Health Milton S. Hershey Medical Center
- Start
- Sep 2003
- Primary completion
- Dec 2012
- Modality
- Hematopoietic Stem Cells
- Countries
- 1
01
Overview
Phase 2, open-label trial of umbilical cord blood in leukemia, lymphoma, myelodysplastic syndrome (MDS) and 9 more (4 arms), sponsored by Penn State Health Milton S. Hershey Medical Center. Primary endpoints: Impact of the use of umbilical cord blood as a source of hematopoietic stem cells, Incidence of graft-versus-host disease and 1 more. Status: unknown.
02
Drugs
umbilical cord blood
03
Conditions
leukemialymphomamyelodysplastic syndrome (MDS)neuroblastomasarcoma
Beyond the preview
Go deeper on NCT00084695.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00084695.